<DOC>
	<DOCNO>NCT01353768</DOCNO>
	<brief_summary>GSK conduct global retrospective chart review patient treat zanamivir part Compassionate Use Program ( CUP ) , effort collect much information possible use investigational drug . The retrospective chart review intend gain well understanding safety profile investigational zanamivir clinical outcome large number patient treat outside clinical trial setting .</brief_summary>
	<brief_title>Zanamivir Aqueous Solution Compassionate Use Program Retrospective Chart Review Study</brief_title>
	<detailed_description>This observational , retrospective , multi-centre , cohort data collection study . The CUP retrospective review study design collect safety clinical outcome data pediatric pregnant patient ( collectively refer `` Tier 1 '' cohort ) treat globally within CUP 2009/2010 pandemic ( May 2009 ) 31 January 2011 . The study also attempt collect data adult patient ( refer `` Tier 2 '' cohort ) treat site identify Tier 1 patient . The treat physician site receive letter GSK medical director invite him/her participate retrospective chart review study . Physicians ( delegate ) agree participate receive study-related documentation [ include protocol case report form ( CRF ) ] orient site study detail CRF . For purpose study , term `` site '' generally refer hospital in-patient treatment provide . The retrospective chart review monitor via remote visit telephone . The interviewer Kendle associate assign study direct access patient 's source document medical record conduct study . The physician/delegate review patient 's chart record data paper CRF . The CRF English language . Site personnel mail complete CRFs Kendle . Kendle review CRF data quality , conduct remote monitoring visit via telephone address data query , require . No visit participate site plan .</detailed_description>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Zanamivir</mesh_term>
	<criteria>1 . Pediatric pregnant patient receive zanamivir aqueous solution part Compassionate Use Program May 2009 31 January 2011 ( Tier 1 cohort ) . 2 . Adult patient ( Tier 2 cohort ) receive zanamivir aqueous solution part Compassionate Use Program May 2009 31 January 2011 , treat site Tier 1 patient . 1 . Adult patient receive zanamivir aqueous solution nonTier 1 site . 2 . Pediatric pregnant patient receive zanamivir aqueous solution part Compassionate Use Program 31 January 2011 .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Influenza</keyword>
</DOC>